As of April 16, 2025, EyePoint Pharmaceuticals (EYPT) has a market cap of $0.39 billion USD. According to our data, EyePoint Pharmaceuticals is ranked No.6226 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $0.39 B |
-23.36%
|
Dec 31, 2024 | $0.51 B |
-67.76%
|
Dec 29, 2023 | $1.58 B |
560.29%
|
Dec 30, 2022 | $0.24 B |
-71.41%
|
Dec 31, 2021 | $0.84 B |
86.02%
|
Dec 31, 2020 | $0.45 B |
-57.55%
|
Dec 31, 2019 | $1.06 B |
-17.99%
|
Dec 31, 2018 | $1.29 B |
75.00%
|
Dec 29, 2017 | $0.74 B |
-36.84%
|
Dec 30, 2016 | $1.17 B |
-64.52%
|
Dec 31, 2015 | $3.29 B |
17.27%
|
Dec 31, 2014 | $2.81 B |
3.53%
|
Dec 31, 2013 | $2.71 B |
228.10%
|
Dec 31, 2012 | $0.83 B |
9.01%
|
Dec 30, 2011 | $0.76 B |
-78.28%
|
Dec 31, 2010 | $3.49 B |
42.34%
|
Dec 31, 2009 | $2.45 B |
281.91%
|
Dec 31, 2008 | $0.64 B |
-70.25%
|
Dec 31, 2007 | $2.16 B |
-59.49%
|
Dec 29, 2006 | $5.32 B |
-63.89%
|
Dec 30, 2005 | $14.74 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Alimera Sciences
ALIM
|
$0.30 B |
0.000 M
|
![]() USA
|
![]() Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
![]() USA
|
![]() Adverum Biotechnologies
ADVM
|
$67.19 M |
-0.000 M
|
![]() USA
|
![]() Kodiak Sciences
KOD
|
$0.12 B |
-0.000 M
|
![]() USA
|
![]() Ocular Therapeutix
OCUL
|
$1.20 B |
-0.000 M
|
![]() USA
|
![]() Clearside Biomedical
CLSD
|
$63.40 M |
0.000 M
|
![]() USA
|
![]() Outlook Therapeutics
OTLK
|
$45.34 M |
-0.000 M
|
![]() USA
|
![]() Novartis
NVS
|
$217.12 B |
0.003 M
|
![]() Switzerland
|
![]() AbbVie
ABBV
|
$312.76 B |
-0.013 M
|
![]() USA
|
![]() Bausch + Lomb
BLCO
|
$4.21 B |
0.000 M
|
![]() Canada
|
![]() Biogen
BIIB
|
$17.12 B |
0.000 M
|
![]() USA
|
Market Cap | = | EYPT Stock Price | * | EYPT Shares Outstanding |
= | $5.67 | * | 68.73 M | |
= | $0.39 B |